HomeRNAC • NASDAQ
add
Cartesian Therapeutics Inc
Previous close
$12.05
Day range
$11.51 - $12.05
Year range
$8.91 - $41.87
Market cap
306.48M USD
Avg Volume
126.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | -759.00K | -109.18% |
Operating expense | 7.09M | -56.62% |
Net income | -10.25M | 94.23% |
Net profit margin | 1.35K | 162.85% |
Earnings per share | — | — |
EBITDA | -18.67M | 22.39% |
Effective tax rate | -2.88% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 212.61M | 176.44% |
Total assets | 435.02M | 42.61% |
Total liabilities | 441.82M | -0.64% |
Total equity | -6.80M | — |
Shares outstanding | 25.91M | — |
Price to book | -46.35 | — |
Return on assets | -10.76% | — |
Return on capital | -424.00% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -10.25M | 94.23% |
Cash from operations | -7.00M | 69.93% |
Cash from investing | -354.00K | -105.45% |
Cash from financing | 783.00K | -94.44% |
Net change in cash | -6.59M | -144.73% |
Free cash flow | -2.91M | -105.41% |
About
Founded
2007
Headquarters
Website
Employees
66